Local treatment for scleritis secondary to Wiskott-Aldrich syndrome

J Fr Ophtalmol. 2016 Mar;39(3):e63-4. doi: 10.1016/j.jfo.2014.12.007. Epub 2016 Mar 4.

Authors

M Randon¹, J-M Michot², O Lambotte², M Labetoulle¹, A Rousseau³

Affiliations

¹ Department of Ophthalmology, Bicêtre Hospital, 78, rue du Général-Leclerc, 94275 Le Kremlin-Bicêtre, France.
² Department of Internal Medicine and Clinical Immunology, Bicêtre Hospital, 78, rue du Général-Leclerc, 94275 Le Kremlin-Bicêtre, France.
³ Department of Ophthalmology, Bicêtre Hospital, 78, rue du Général-Leclerc, 94275 Le Kremlin-Bicêtre, France. Electronic address: antoine.rousseau@bct.aphp.fr.

PMID: 26951873
DOI: 10.1016/j.jfo.2014.12.007

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Dexamethasone / administration & dosage*
Humans
Injections, Intraocular
Male
Ophthalmic Solutions
Scleritis / drug therapy*
Scleritis / etiology
Wiskott-Aldrich Syndrome / complications
Wiskott-Aldrich Syndrome / drug therapy*
Young Adult

Substances

Ophthalmic Solutions
Dexamethasone